Skip to main content

Table 3 Median, interquartile range (IQR), mean, standard deviation (SD) and p-values of outcome measurements at 12-week follow up

From: An evidence-based self-management package for urinary incontinence in older women: a mixed methods feasibility study

Variable

Dimensions

Intervention group

Control group

p-value

n

%

Median

IQR

Mean

SD

n

%

Median

IQR

Mean

SD

EQ-5D-5L

Mobility

            

0.478

No/slight problem

21

87.5%

    

20

80.0%

     

Moderate/Severe/extreme problem

3

12.5%

    

5

20.0%

     

Selfcare

            

0.322

No/slight problem

24

100.0%

    

24

96.0%

     

Moderate/Severe/extreme problem

0

0.0%

    

1

4.0%

     

Usual activities

            

0.950

No/slight problem

20

83.3%

    

21

84.0%

     

Moderate/Severe/extreme problem

4

16.7%

    

4

16.0%

     

Pain & discomfort

            

0.682

No/slight problem

17

70.8%

    

19

76.0%

     

Moderate/Severe/extreme problem

7

29.2%

    

6

24.0%

     

Anxiety & depression

            

0.957

No/slight problem

21

87.5%

    

22

88.0%

     

Moderate/Severe/extreme problem

3

12.5%

    

3

12.0%

     

Index

24

 

0.92

0.26

0.86

0.16

25

 

0.88

0.16

0.83

0.19

0.471

VAS

24

 

80.00

20.00

78.54

17.60

25

 

75.00

15.00

73.00

14.93

0.240

KHQ

Part I

             

General health perception (0-100)

24

 

25.00

12.50

30.21

23.29

25

 

25.00

25.00

31.00

20.77

0.900

Incontinence impact (0-100)

24

 

33.33

33.33

45.83

21.56

25

 

33.33

33.33

49.33

25.68

0.609

Part II

             

Role limitations (0-100)

24

 

16.67

33.33

20.14

23.04

25

 

33.33

33.33

30.67

23.90

0.123

Physical limitations (0-100)

24

 

16.67

33.33

22.92

22.42

25

 

33.33

33.33

32.67

24.76

0.156

Social limitations (0-100)

24

 

0.00

5.56

5.56

10.87

25

 

0.00

11.11

8.22

20.98

0.581

Personal relationships (0-100)

16

 

0.00

0.00

0.00

0.00

16

 

0.00

0.00

5.21

11.74

0.086

Emotions (0-100)

24

 

11.11

22.22

12.50

14.40

25

 

11.11

22.22

16.44

20.06

0.435

Sleep/energy (0-100)

24

 

16.67

33.33

27.08

31.01

25

 

33.33

33.33

37.33

31.28

0.255

Severity measures (0-100)

24

 

25.00

16.67

26.39

17.66

25

 

33.33

25.00

37.33

20.99

0.055

Part III

             

Symptom severity scale (0-30)

24

 

6.00

4.00

6.38

2.93

25

 

10.00

4.00

9.04

3.51

0.006

ICIQ-UI SF

Scale (0-21)

24

 

4.50

4.00

5.38

2.83

25

 

9.00

5.00

7.76

4.08

0.022

GSE-UI

Scale (0-120)

24

 

94.50

31.00

89.13

23.86

25

 

67.00

34.00

69.08

25.46

0.007

HADS

Anxiety scale (0-21)

24

 

5.00

6.00

5.13

4.59

25

 

7.00

5.00

7.80

4.65

0.049

Normal

19

79.2%

    

16

64.0%

    

0.593

Mild

2

8.3%

    

4

16.0%

     

Moderate

2

8.3%

    

2

8.0%

     

Severe

1

4.2%

    

3

12.0%

     

Depression scale (0-21)

24

 

2.00

3.50

3.08

3.28

25

 

3.00

3.00

3.44

3.92

0.732

Normal

21

87.5%

    

22

88.0%

    

0.720

Mild

2

8.3%

    

1

4.0%

     

Moderate

1

4.2%

    

1

4.0%

     

Severe

0

0.0%

    

0

      
  1. T-tests for continuous variables and chi-square tests for categorical variables VAS Visual Analogue Scale, KHQ King’s Health Questionnaire, ICIQ-UI SF International Consultation on Incontinence Questionnaire – urinary incontinence short form, GSE-UI Geriatric Self-Efficacy index for urinary incontinence, HADS Hospital Anxiety and Depression Scale
Back to article page

BMC Urology

ISSN: 1471-2490

Contact us